A preclinical model for the identification of therapeutically active transgenes in local cancer immunotherapy
{{output}}
The efficacy of systemic immunotherapies is limited for poorly immunogenic tumors which suppress T cell priming and tumor infiltration. Modern antigen carriers including viral vectors and messenger RNA/lipid nanoparticle (LNP) combinations have renewed the int... ...
